Status | Study |
Completed |
Study Name: Multicenter International Cross-Sectional Evaluation of Pulmonary Alveolar Proteinosis Trial Condition: Pulmonary Alveolar Proteinosis Date: 2016-11-28 Interventions: Other: Retrospective Chart Review No intervention. |
Not yet recruiting |
Study Name: Evaluation of a Single Dose of Inhaled Sargramostim in Patients With Autoimmune Pulmonary Alveolar Proteinosis Condition: Autoimmune Pulmonary Alveolar Proteinosis Date: 2016-11-28 Interventions: Drug: Sargramostim Other Names: Leukine recombinant human GM-C |
Recruiting |
Study Name: European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank Condition: Lung Diseases, Interstitial Pulmonary Alveolar Proteinosis Date: 2016-07-29 |
Active, not recruiting |
Study Name: Pulmonary Alveolar Proteinosis GM-CSF Inhalation Efficacy Trial in Japan Condition: Pulmonary Alveolar Proteinosis, Autoimmune Date: 2016-07-13 Interventions: Drug: Sargramostim Drug: Placebo |
Completed |
Study Name: SK-1401 (rhGM-CSF Agent for Inhalation) GM-CSF Inhalation Pharmacokinetic Study Condition: Pulmonary Alveolar Proteinosis, Autoimmune Date: 2016-07-13 Interventions: Drug: Sargramostim |
Recruiting |
Study Name: Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Condition: Autoimmune Pulmonary Alveolar Proteinosis Date: 2016-02-28 Interventions: Drug: molgramostim molgramosti |
Completed |
Study Name: Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects Condition: Pulmonary Alveolar Proteinosis Bronchiectasis Date: 2015-06-03 Interventions: Drug: Molgramostim Other Name: |
Recruiting |
Study Name: A National Registry For Pulmonary Alveolar Proteinosis Condition: Pulmonary Alveolar Proteinosis Date: 2015-05-28 |
Recruiting |
Study Name: Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP) Condition: Autoimmune Pulmonary Alveolar Proteinosis Date: 2014-09-14 Interventions: Drug: GM-CSF Other Name: HUABEI JIMUXIN |
Recruiting |
Study Name: Evaluation and Treatment Planning of Patients With PAP Using Thrive Ultra Short Echo Time MRI and CT Condition: Pulmonary Alveolar Proteinosis Date: 2014-02-12 |